Hereditary Sensory and Autonomic Neuropathies
15 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Hereditary Sensory and Autonomic Neuropathies| Treatment and condition | Where it stands | Trials |
|---|
| Capivasertib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Carboplatin + ELRAGLUSIB for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Carboplatin + ELRAGLUSIB + Paclitaxel for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dexmedetomidine hydrochloride for dysautonomia, familial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Doxorubicin hydrochloride + ELRAGLUSIB for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Elraglusib for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| ELRAGLUSIB + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| ELRAGLUSIB + NAB-PACLITAXEL + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + Metformin + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| FULVESTRANT + Tersolisib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Irinotecan + ELRAGLUSIB for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Lomustine + ELRAGLUSIB for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| ROC-101 for hereditary sensory and autonomic neuropathies | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| TAMOXIFEN + FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + IMLUNESTRANT + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Tersolisib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|